ASND
Ascendis Pharma A/S
NASDAQ · Healthcare · Biotechnology · DK
$265.71
+2.48%2
Insider buys (3m)
2
Insider sells (3m)
-$380.3K
Net value (3m)
+1.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 28, 2026 | BIENAIME JEAN JACQUES · director | A-Award | 9,160 | $250 |
| Sep 9, 2026 | Bodenhoff Mads · officer: SVP & PAO | Sale | 3,000 | $270 |
| Sep 9, 2026 | Bodenhoff Mads · officer: SVP & PAO | M-Exempt | 3,000 | $110 |
| Sep 3, 2026 | HOLTUG LARS · director | Sale | 236 | $264 |
| Aug 18, 2026 | BIENAIME JEAN JACQUES · director | Purchase | 1,100 | $246 |
| Aug 18, 2026 | BIENAIME JEAN JACQUES · director | Purchase | 900 | $247 |
| Jun 2, 2026 | SMITH SCOTT THOMAS · officer: EVP & Chief Financial Officer | Purchase | 100 | $219 |
| Jun 1, 2026 | SMITH SCOTT THOMAS · officer: EVP & Chief Financial Officer | Purchase | 250 | $223 |
| Jun 1, 2026 | BIENAIME JEAN JACQUES · director | Purchase | 100 | $224 |
| Jun 1, 2026 | BIENAIME JEAN JACQUES · director | Purchase | 200 | $224 |
| May 27, 2026 | BIENAIME JEAN JACQUES · director | Purchase | 200 | $236 |
| May 12, 2026 | JENSEN FLEMMING STEEN · officer: See Remarks | Sale | 19,460 | $238 |
Institutional positioning
13F filings over the trailing two quarters
New 154Increased 242Reduced 206Sold out 38
| Filer | Action | Shares | Filed |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 10,281,496 | May 15, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 10,281,496 | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | New Position | 6,754,846 | Aug 14, 2026 |
| FMR LLC | Reduced | 5,354,756 | Nov 5, 2026 |
| FMR LLC | Reduced | 5,293,120 | Nov 5, 2026 |
| FMR LLC | Reduced | 5,278,865 | Nov 5, 2026 |
| FMR LLC | Reduced | 5,229,070 | Nov 5, 2026 |
| FMR LLC | Reduced | 5,152,165 | Nov 5, 2026 |
| FMR LLC | Reduced | 5,140,805 | Nov 5, 2026 |
| FMR LLC | Reduced | 5,136,282 | Nov 5, 2026 |
| FMR LLC | Reduced | 5,114,369 | Nov 5, 2026 |
| Avoro Capital Advisors LLC | Increased | 5,111,111 | Aug 14, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 5,062,500 | May 15, 2026 |
| FMR LLC | Reduced | 4,938,461 | Nov 5, 2026 |
| FMR LLC | Reduced | 4,922,555 | Nov 5, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 28, 2026